Life sciences, Current


Cytomos plans to revolutionise cell analysis by bringing understanding to production and intelligence to process automation to make cell therapies possible at scale.

Cytomos  Dielectric Spectroscopy (CDS) is a proprietary and patented cell analysis technology spanning integrated sensors through to machine learning enhanced algorithms. It requires no interaction with cells under test, no expensive and  time-consuming cell labelling,  Cytomos provides benefits across the manufacturing industry underpinned by its uniquely scalable technology.

Year of investment



Sarah Hardy

Seeking investment?

Our team is always actively seeking new investment opportunities. They review circa 200 business plans each year.

Become a member

Our members are genuinely motivated to give something back and build great businesses in Scotland, as well as making a financial return.

We use cookies to give you the best experience. Cookie Policy

Preloader image